Development and validation of hub genes for lymph node metastasis in patients with prostate cancer

J Cell Mol Med. 2020 Apr;24(8):4402-4414. doi: 10.1111/jcmm.15098. Epub 2020 Mar 4.

Abstract

Lymph node metastasis is one of the most important independent risk factors that can negatively affect the prognosis of prostate cancer (PCa); however, the exact mechanisms have not been well studied. This study aims to better understand the underlying mechanism of lymph node metastasis in PCa by bioinformatics analysis. We analysed a total of 367 PCa cases from the cancer genome atlas database and performed weighted gene co-expression network analysis to explore some modules related to lymph node metastasis. Gene Ontology analysis and pathway enrichment analysis were conducted for functional annotation, and a protein-protein interaction network was built. Samples from the International Cancer Genomics Consortium database were used as a validation set. The turquoise module showed the most relevance with lymph node metastasis. Functional annotation showed that biological processes and pathways were mainly related to activation of the processes of cell cycle and mitosis. Four hub genes were selected: CKAP2L, CDCA8, ERCC6L and ARPC1A. Further validation showed that the four hub genes well-distinguished tumour and normal tissues, and they were good biomarkers for lymph node metastasis of PCa. In conclusion, the identified hub genes facilitate our knowledge of the underlying molecular mechanism for lymph node metastasis of PCa.

Keywords: hub genes; lymph node metastasis; prostate cancer; weighted gene co-expression network analysis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actin-Related Protein 2-3 Complex / genetics*
  • Adult
  • Aged
  • Biomarkers, Tumor / genetics
  • Cell Cycle Proteins / genetics*
  • Cytoskeletal Proteins / genetics*
  • DNA Helicases / genetics*
  • Gene Expression Regulation, Neoplastic / genetics
  • Humans
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Prognosis
  • Prostatic Neoplasms / genetics*
  • Prostatic Neoplasms / pathology
  • Protein Interaction Maps / genetics

Substances

  • ARPC1A protein, human
  • Actin-Related Protein 2-3 Complex
  • Biomarkers, Tumor
  • CDCA8 protein, human
  • CKAP2 protein, human
  • Cell Cycle Proteins
  • Cytoskeletal Proteins
  • DNA Helicases
  • ERCC6L protein, human